RNAi to treat SARS‐CoV‐2—variant proofing the next generation of therapies

MLA

Nigel A J McMillan, et al. “RNAi to Treat SARS‐CoV‐2—variant Proofing the next Generation of Therapies.” EMBO Molecular Medicine, vol. 14, no. 4, Mar. 2022, pp. 1–3. EBSCOhost, https://doi.org/10.15252/emmm.202215811.

APA

Nigel A J McMillan, Kevin V Morris, & Adi Idris. (2022). RNAi to treat SARS‐CoV‐2—variant proofing the next generation of therapies. EMBO Molecular Medicine, 14(4), 1–3. https://doi.org/10.15252/emmm.202215811

Chicago

Nigel A J McMillan, Kevin V Morris, and Adi Idris. 2022. “RNAi to Treat SARS‐CoV‐2—variant Proofing the next Generation of Therapies.” EMBO Molecular Medicine 14 (4): 1–3. doi:10.15252/emmm.202215811.